Return On Equity of Cidara Therapeutics, Inc. from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cidara Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • Cidara Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -60%, a 73% increase year-over-year.
  • Cidara Therapeutics, Inc. annual Return On Equity for 2024 was -173%, a 94% increase from 2023.
  • Cidara Therapeutics, Inc. annual Return On Equity for 2023 was -2682%, a 877% decline from 2022.
  • Cidara Therapeutics, Inc. annual Return On Equity for 2022 was 345%.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Cidara Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -60% +159% +73% 01 Jul 2025 30 Sep 2025
Q2 2025 -51% +409% +89% 01 Apr 2025 30 Jun 2025
Q1 2025 -133% -625% -127% 01 Jan 2025 31 Mar 2025
Q4 2024 -173% +2509% +94% 01 Oct 2024 31 Dec 2024
Q3 2024 -219% -4965% -105% 01 Jul 2024 30 Sep 2024
Q2 2024 -460% +4290% +90% 01 Apr 2024 30 Jun 2024
Q1 2024 492% +252% +105% 01 Jan 2024 31 Mar 2024
Q4 2023 -2682% -3027% -877% 01 Oct 2023 31 Dec 2023
Q3 2023 4746% +3454% +267% 01 Jul 2023 30 Sep 2023
Q2 2023 -4749% -7433% -277% 01 Apr 2023 30 Jun 2023
Q1 2023 240% +950% 01 Jan 2023 31 Mar 2023
Q4 2022 345% +918% 01 Oct 2022 31 Dec 2022
Q3 2022 1292% +1986% 01 Jul 2022 30 Sep 2022
Q2 2022 2684% +3007% 01 Apr 2022 30 Jun 2022
Q1 2022 -710% -347% -95% 01 Jan 2022 31 Mar 2022
Q4 2021 -573% -360% -169% 01 Oct 2021 31 Dec 2021
Q3 2021 -695% -536% -337% 01 Jul 2021 30 Sep 2021
Q2 2021 -323% -227% -236% 01 Apr 2021 30 Jun 2021
Q1 2021 -363% -273% -301% 01 Jan 2021 31 Mar 2021
Q4 2020 -213% -112% -111% 01 Oct 2020 31 Dec 2020
Q3 2020 -159% -73% -85% 01 Jul 2020 30 Sep 2020
Q2 2020 -96% +13% +12% 01 Apr 2020 30 Jun 2020
Q1 2020 -91% +1.6% +1.7% 01 Jan 2020 31 Mar 2020
Q4 2019 -101% -11% -12% 01 Oct 2019 31 Dec 2019
Q3 2019 -86% +5.7% +6.2% 01 Jul 2019 30 Sep 2019
Q2 2019 -110% -13% -13% 01 Apr 2019 30 Jun 2019
Q1 2019 -92% +14% +13% 01 Jan 2019 31 Mar 2019
Q4 2018 -90% -0.02% -0.02% 01 Oct 2018 31 Dec 2018
Q3 2018 -92% -9.3% -11% 01 Jul 2018 30 Sep 2018
Q2 2018 -97% -21% -28% 01 Apr 2018 30 Jun 2018
Q1 2018 -106% -42% -66% 01 Jan 2018 31 Mar 2018
Q4 2017 -90% -34% -60% 01 Oct 2017 31 Dec 2017
Q3 2017 -82% -33% -68% 01 Jul 2017 30 Sep 2017
Q2 2017 -76% -35% -85% 01 Apr 2017 30 Jun 2017
Q1 2017 -64% -32% -97% 01 Jan 2017 31 Mar 2017
Q4 2016 -56% -16% -40% 01 Oct 2016 31 Dec 2016
Q3 2016 -49% +4% +7.5% 01 Jul 2016 30 Sep 2016
Q2 2016 -41% 01 Apr 2016 30 Jun 2016
Q1 2016 -33% 01 Jan 2016 31 Mar 2016
Q4 2015 -40% 01 Oct 2015 31 Dec 2015
Q3 2015 -53% 01 Jul 2015 30 Sep 2015

Cidara Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -173% +2509% +94% 01 Jan 2024 31 Dec 2024
2023 -2682% -3027% -877% 01 Jan 2023 31 Dec 2023
2022 345% +918% 01 Jan 2022 31 Dec 2022
2021 -573% -360% -169% 01 Jan 2021 31 Dec 2021
2020 -213% -112% -111% 01 Jan 2020 31 Dec 2020
2019 -101% -11% -12% 01 Jan 2019 31 Dec 2019
2018 -90% -0.02% -0.02% 01 Jan 2018 31 Dec 2018
2017 -90% -34% -60% 01 Jan 2017 31 Dec 2017
2016 -56% -16% -40% 01 Jan 2016 31 Dec 2016
2015 -40% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.